Bayer's Weinand Slams Silo Thinking, Short-Termism In Medicines Valuation

 
• By Eleanor Malone

Healthcare decision makers need to get out of their short-termist, siloed thinking when it comes to medicines reimbursement if healthcare systems are to remain sustainable, argued Bayer Pharma chief Dieter Weinand at the company's annual pharma media day.

Silos
Silo thinking hampers medicines evaluation, says Bayer exec • Source: Shutterstock

More from Drug Pricing

More from Scrip